Results
1 -
9 of
9
(Click
here to explore results)
- Orphan Drugs and Rare Diseases, Chapter 9 Discovery and Development of Tafamidis for the Treatment of TTR Familial Amyloid Polyneuropathy. Richard Labaudinière
, 2014
, Pages 202-229
- Protein–Protein Interaction Regulators, CHAPTER 10 Small-molecule Modulators of Protein–Protein Interactions: Focus on 14-3-3 PPIs. L. Iralde-Lorente, M. Botta, C. Ottmann
, 2021
, Pages 249-279
- Cardiovascular and Metabolic Disease: Scientific Discoveries and New Therapies, Chapter 10 New Drug Design and Therapeutic Development for Heart Failure. Elnaz Menhaji-Klotz, Thomas V. Magee
, 2015
, Pages 186-218
- Orphan Drugs and Rare Diseases, Contents
, 2014
, Pages P013-P022
- Orphan Drugs and Rare Diseases, Subject Index
, 2014
, Pages 448-463
- Protein–Protein Interaction Regulators, Subject Index
, 2021
, Pages 373-380
- Orphan Drugs and Rare Diseases, Chapter 4 Treating Rare Diseases: Business Model for Orphan Drug Development. Cory Williams
, 2014
, Pages 83-111
- Sustainable Organic Synthesis: Tools and Strategies, CHAPTER 16 Sustainable Tools for Flow Chemistry. Francesco Ferlin, Luigi Vaccaro
, 2022
, Pages 447-471
- Cardiovascular and Metabolic Disease: Scientific Discoveries and New Therapies, Subject Index
, 2015
, Pages 366-376